Glucose Monitoring Devices Market is set to reach US$ 67.74 billion by 2033, at a strong CAGR of 17.0%. North America leads the market with 39% market share.

Glucose Monitoring Devices Market reached US$ 16.65 billion in 2024 and is expected to reach US$ 67.74 billion by 2033, growing at a CAGR of 17.0% during the forecast period 2025-2033.

Glucose Monitoring Devices are medical tools used to measure and track blood sugar levels in real-time, aiding diabetes management, enabling personalized treatment, and improving overall patient health and lifestyle control.

DataM Intelligence unveils its latest report on the " Glucose Monitoring Devices Market size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/glucose-monitoring-devices-market?prtk

United States: Key Industry Developments (2025)

✅ December 2025: Dexcom launched its Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System in the U.S. market on Dec. 1, offering extended sensor wear up to 15.5 days and improved real‐time glucose tracking for adults living with diabetes.

✅ October 2025: Walmart began selling Abbott's Lingo over‐the‐counter continuous glucose monitor in more than 3,500 physical and online retail locations, marking a major expansion of glucose monitor availability beyond traditional prescription channels.

✅ April 2025: The FDA cleared the Dexcom G7 15 Day CGM system for adults aged 18 and older, enabling broader access to extended wear continuous glucose monitoring technology.

Japan: Key Industry Developments (2025)

✅ September 2025: Real‐world data presented at EASD 2025 demonstrated that continuous glucose monitoring provides cost‐effective improvements in managing Type 2 diabetes with insulin therapy in Japan, boosting clinical adoption of CGM technologies.

✅ May 2025: Kakao Healthcare launched the AI‐powered CGM companion app "PASTA" in Japan, integrating sensor data from I‐sens Inc.'s Caresens Air and Dexcom G7 systems to enhance diabetes self‐management tools for users.

✅ April 2025: Sequel Med Tech and Senseonics announced plans to integrate the Eversense 365 implantable glucose sensor with Sequel's automated insulin delivery system, aiming to simplify day‐to‐day diabetes management.

📌 Glucose Monitoring Devices Market 2025-26 M&A Deals
→ In October 2025, OSR Holdings, Inc. acquired Woori IO Co., Ltd., a South Korean pioneer in noninvasive glucose monitoring technology. The acquisition was executed via a share exchange valued at approximately KRW 15 billion (USD 10.5 million), making Woori IO a wholly owned subsidiary and bringing needle‐free CGM technology into OSR's portfolio.

→ In July 2025, OSR Holdings signed a term sheet to acquire Woori IO, laying the groundwork for the October closing. Under this agreement, Woori IO shareholders are to receive newly issued OSR affiliate shares with potential conversion into OSR Holdings common stock subject to stock price targets.

→ In the first half of 2025, Dexcom and ŌURA partnership launched preparations (stemming from late‐2024 investment): Dexcom made a strategic investment of USD 75 million in ŌURA's Series D funding round and established a strategic partnership to integrate Dexcom glucose biosensor data with Oura Ring health metrics (sleep, activity, heart rate) and to co‐market the combined solution. While the investment occurred in November 2024, the integration efforts and partnership activities actively rolled into 2025 with planned product/data integrations in the first half of the year.

Glucose Monitoring Devices Market Drivers:-
⏩ An aging global population contributes to higher diabetes incidence and thus expanded use of glucose monitoring devices. Older adults are disproportionately affected by Type 2 diabetes and require frequent glucose checks for safe disease management.

⏩ Continuous Glucose Monitoring (CGM) systems offering real‐time glucose trends and reduced user burden

⏩ Bluetooth and smartphone integration, allowing data sharing and remote clinician interaction

⏩ AI‐powered predictive analytics and healthier behavior nudges in apps/interfaces

⏩ Emerging non‐invasive sensing technologies (optical, sweat‐based, wearable patches) under development.

⏩ Healthcare is shifting toward preventive and patient‐empowered models. Patients increasingly adopt glucose monitoring tools as part of self‐management routines rather than episodic clinical visits.

⏩ Expanded reimbursement for CGM devices in many developed markets has boosted adoption among eligible patients

⏩ National health programs in countries like the U.S. and India are allocating funding to diabetes management initiatives

📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=glucose-monitoring-devices-market?prtk

Glucose Monitoring Devices Major Players:-

Abbott Laboratories, Medtronic, F. Hoffmann-La Roche Ltd, LifeScan IP Holdings, LLC, Sanofi SA, B Braun Melsungen AG, Dexcom, Senseonics, Inc., Nova Biomedical Corporation, and Omnis Health LLC, among others.

Key players highlights:-

Dexcom, Inc. - Market leader in continuous glucose monitoring (CGM) technology, known for high accuracy and strong innovation focus. Holds ~44% of CGM‐related patents, reflecting broad influence in the segment.

Abbott Laboratories - Leading with its FreeStyle Libre CGM systems, widely adopted globally for real‐time glucose tracking. Together with top peers, Abbott helps drive >75% of the overall glucose monitoring device market share.

F. Hoffmann‐La Roche Ltd - Strong presence mainly in traditional blood glucose monitoring with the Accu‐Chek brand and integrated diabetes care solutions. Ranked among the top market holders alongside Abbott and Dexcom.

Medtronic - Major player combining CGM sensors with insulin delivery systems (e.g., MiniMed), enhancing automated diabetes care. Contributes significant share behind Dexcom and Abbott in overall market dynamics.

LifeScan IP Holdings, LLC - Known for OneTouch blood glucose meters and test strips; a longstanding brand in SMBG devices. Part of the core competitor group in conventional glucose monitoring markets.

Glucose Monitoring Devices Regional Highlights

North America
• Largest regional share at around 39% of the global glucose monitoring devices market, led by the U.S. dominance.
• Strong adoption of advanced CGM and SMBG technologies supported by favorable reimbursement and regulatory approvals.
• Continuous innovation and expanded over‐the‐counter device access driving consistent market growth.

Europe
• Holds approximately 28.3% share of the total glucose monitoring market.
• Growth driven by diabetes awareness programs, digital healthcare solutions, and supportive reimbursement frameworks.
• Increased adoption of eco‐friendly and integrated health apps linking with CGM systems.

Asia Pacific
• Accounts for roughly 22.1% regional share, with fastest emerging growth.
• Rapid market expansion driven by rising diabetes prevalence and improving healthcare access in China, India and other APAC countries.
• Government initiatives and cost‐competitive device availability accelerating adoption.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/glucose-monitoring-devices-market?prtk

Glucose Monitoring Devices market segmentation :

The Cleaning Robot Market is segmented to address diverse customer needs and applications. By Type, it includes vacuum, floor-scrubbing, and window-Glucose Monitoring Devices. By Product, segmentation covers commercial and household Glucose Monitoring Devices. By Operation Mode, robots are classified as autonomous or semi-autonomous. By End-User, the market serves residential, commercial, and industrial sectors. By Sales Channel, products are distributed through online platforms, offline retail stores, and direct sales, ensuring wide accessibility.

Q1: What is driving the growth of the Glucose Monitoring Devices market?
A: Rising diabetes prevalence, technological advancements in continuous monitoring, and increasing health awareness are key growth drivers.

Q2: Which regions dominate the Glucose Monitoring Devices market?
A: North America leads due to advanced healthcare infrastructure, while Asia-Pacific shows rapid adoption due to increasing diabetic population.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.